Collagen and Gelatin Market Size, Scope, Trends and Future Outlook 2030

Collagen & Gelatin Market Size, Share & Trends Analysis By Source, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Collagen & Gelatin Market Size, Share & Trends Analysis By Source, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Feb 2022 Report ID: PHAR2204 Pages: 1 - 234 Formats*:     
Category : Pharmaceutical
Global Collagen & Gelatin Market Overview:

According to SPER Market Research, the collagen and gelatin market estimated to reach USD 1396 million by 2030 with a CAGR of 6.8%. Diabetes is one of the leading metabolic disorders. Diabetes patients also may suffer from foot infections and wounds which require regenerative treatments for healing purpose. 

Impact of COVID-19 on the Collagen & Gelatin Market
During the COVID-19 pandemic, lockdowns were imposed and services unrelated to coronavirus were either postponed or cancelled. Thus, collagen and gelatin market have suffered with the inception of the pandemic. Many manufacturers were unable to run the production plants due to lack of logistics and disruption of supply chains.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Source, By Application, By End User
 Geographies covered North America, Europe, APAC, Latin America and the Middle East & Africa
 Companies CoveredAdvanced BioMatrix, Bioregen Technologies, Collagen Matrix, Inc., Collagen Solutions PLC, Collplant Biotechnologies, Cologenesis Healthcare Pvt Ltd, DermaRite Industries, LL, Eucare Pharmaceuticals Private Limited, Geistlich Pharma AG, Gelita AG, Integra Lifesciences, Jellagen, Matricel GmbH, MedSkin Solutions Dr. Suwelack AG, Meril Lifesciences, Nitta Gelatin Inc., PB Leiner, Rousselot, Royal DSM, Smith & Nephew, Symatese, Synerheal Pharmaceuticals, WEISHARDT, Xiamen Hyfine Gelatin, Zimmer Biomet
Driver: Rising prevalence of cancer, diabetes and chronic wounds
Due the rising prevalence of cancer and diabetes, incidence of complex wounds has also increased requiring higher medical expenses. In diabetes, about 15% of total patients suffer from diabetic foot. The increasing prevalence of such wounds is driving the growth of collagen & gelatin market for regenerative products as such grafts and matrices. 

Restraints: Availability of substitutes 
Many substitutes are available for collagen and gelatin such as cellulose, alginate, chitosan which offer better healing, regeneration and efficiency. These substitutes can be used in regenerative therapies. The availability of these substitutes can hinder the growth of collagen & gelatin market.

Opportunity: Acceleration of product development
With the implementation of 21st Century Cures Act in December 2016, the product development process has been accelerated. The fast-track approval process assists the novel regenerative medicines to fasten the approval process and be available to the patients. This also supports the research and development to provide more efficient and faster treatment options. 

Challenge: Trend shift towards veganism
Many consumers from developed countries are adopting veganism as a lifestyle. Thus, they do not prefer to consume any product of animal origin. The developing countries are also slowly adopting this culture. This shift in overall change in lifestyle can pose significant challenge to the growth of this market.

Collagen & Gelatin Market Segmentation:

By Source: Based on source, market has been segmented into bovine, porcine and other sources

By Application: Based on source, market has been segmented into Pharmaceutical, Food, Beverage, Cosmetic, Nutraceutical, Others

By End User: Based on end user, the market is segmented into hospitals and surgical centres. Hospitals have the largest share of this market by end user due to availability of skilled staff, advanced equipment and large number of surgeries performed at the hospitals.

By Region: North America owns the largest share of this market owing to rising geriatric population and presence of leading players of collagen & gelatin market in this geographical area.

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Collagen & Gelatin Market
4.4. Market Trends

5. Global Collagen & Gelatin Market, By Source, 2019-2030 (USD Million)
5.1. Bovine
5.2. Porcine
5.3. Other Sources

6. Global Collagen & Gelatin Market, By Application, 2019-2030 (USD Million)
6.1. Pharmaceutical 
6.2. Food
6.3. Beverage
6.4. Cosmetic
6.5. Nutraceutical
6.6. Others

7. Global Collagen & Gelatin Market, By End User, 2019-2030 (USD Million)
7.1. Hospitals 
7.2. Surgical Centres

8. Global Collagen & Gelatin Market, By Geography, 2019-2030 (USD Million)
8.1. North America
8.1.1. US
8.1.2. Canada
8.2. Europe
8.2.1. Germany
8.2.2. UK
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
8.3. Asia-Pacific
8.3.1. China
8.3.2. Japan
8.3.3. India
8.3.4. Rest of Asia-Pacific
8.4. Rest of the World
8.4.1. Latin America
8.4.2. Middle East & Africa

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis, By Key Players
9.3. Competitive Scenario 
9.3.1. Product Launches
9.3.2. Partnerships, Collaborations and Agreements
9.3.3. Acquisitions
9.3.4. Expansions
9.3.5. Other Developments

10. Company Profiles
10.1. Advanced BioMatrix
10.2. Bioregen Technologies
10.3. Collagen Matrix, Inc.
10.4. Collagen Solutions PLC
10.5. Collplant Biotechnologies
10.6. Cologenesis Healthcare Pvt Ltd
10.7. DermaRite Industries, LL
10.8. Eucare Pharmaceuticals Private Limited
10.9. Geistlich Pharma AG
10.10. Gelita AG
10.11. Integra Lifesciences
10.12. Jellagen
10.13. Matricel GmbH
10.14. MedSkin Solutions Dr. Suwelack AG
10.15. Meril Lifesciences 
10.16. Nitta Gelatin Inc.
10.17. PB Leiner
10.18. Rousselot
10.19. Royal DSM
10.20. Smith & Nephew
10.21. Symatese
10.22. Synerheal Pharmaceuticals
10.24. Xiamen Hyfine Gelatin
10.25. Zimmer Biomet

11. Appendix

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.




Not able to find what you are looking for? Need customization in the existing report?
Click Here
  • 15% off
    $ 4250
  • 20% off
    $ 5650
  • 25% off
    $ 7450
Pre-Purchase Inquiry
Request Customization
100% Secure Payment

SPER American Express
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join Our SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Johnson & Johnson


Market Research

We are the leading, full-service global market research and consulting company.

iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us